Document is current
Any future updates will be listed below
-
Authors
Andrei, Adin-Cristian http://orcid.org/0000-0001-8129-3981
Cox, James L.
Shah, Sanjiv
Malaisrie, Sukit Chris
Mehta, Christopher
Efimov, Igor R.
Churyla, Andrei
Kruse, Jane
McCarthy, Patrick M.
- License Information
-
More Information
Article History
Received: 9 May 2024
Accepted: 3 September 2024
First Online: 1 October 2024
Declarations
:
: Not applicable.
: Not applicable.
: ACA, SS, CM, AC, JK: none. JLC: Adagio Medical, Inc.—Laguna Hills, California (PRIVATE) Board of Directors, Stockholder, Consultant; Atricure, Inc.—Mason, Ohio (PUBLIC) Stockholder, Consultant; PAVmed, Inc.—New York City, NY (PUBLIC) Board of Directors, Stockholder; Lucid Diagnostics, Inc.—New York City, NY (PUBLIC) Board of Directors, Stockholder; PotentiaMetrics, Inc.—St. Louis, Missouri (PRIVATE) Clinical Advisory Board, Stockholder. IRE: Consultant fees from AliveCor, Samsung, Zoll. NuSera Biosystems: co-founder and stockholder. ER: NuSera Biosystems chief medical officer and stockholder. SCM: Consultant fees and research funding from Edwards, Artivion, Terumo. PMM: Edwards Lifesciences: speaking fees and royalties; Medtronic and Atricure: speaking fees; Abbott: Surgical primary investigator REPAIR-MR Trial (unpaid); advisory board.
